Data / Drug companies / Ambi Enterprises LLC
Ambi Enterprises LLC: 8 products in the FDA NDC directory, labeler code 73453
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Ambi Enterprises LLC (labeler code 73453) lists 8 products in the FDA National Drug Code Directory, covering 5 finished drugs by generic name. By type: 8 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on January 30, 2026.
The request: Watch Ambi Enterprises LLC (FDA labeler code 73453): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 73453
- Products in commercial distribution
- 8
- Packages
- 9
- Finished drugs by generic name
- 5
- Prescription products
- 0
- Over the counter products
- 8
- Flagged as original packager
- 8 of 8 products that carry the flag
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- June 15, 2014
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 8 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 8 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Salicylic acid | 4 | 330 |
| Alcohol | 1 | 293 |
| Octisalate, octocrylene, avobenzone | 1 | 2 |
| Homosalate 15%, octisalate 5%, octocrylene 3%, avobenzone 3% | 1 | 1 |
| Avobenzone, octisalate, octocrylene | 1 | 54 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 3 | 37.5% |
| Liquid | 2 | 25% |
| Gel | 2 | 25% |
| Kit | 1 | 12.5% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Even and Clear Exfoliating Wash | 73453-113 | Liquid | Over the counter monograph drugs | January 30, 2026 |
| Ambi Even and Clear Facial Moisturizer | 73453-112 | Cream | Over the counter monograph drugs | December 22, 2025 |
| Ambi Even and Clean Skin Tone Kit | 73453-110 | Kit | Over the counter monograph drugs | December 19, 2025 |
| AMBI Even and Clear Facial Moisturizer SPF-30 | 73453-233 | Cream | Over the counter monograph drugs | September 25, 2021 |
| AMBI Even and Clear Exfoliating Wash Acne Treatment | 73453-166 | Gel | Over the counter monograph drugs | July 13, 2020 |
| AMBI Soothing Hand sanitizer | 73453-143 | Gel | Over the counter monograph drugs | May 20, 2020 |
| AMBI SKINCARE Even and Clear Daily Facial Moisturizer SPF 30 | 73453-073 | Cream | Over the counter monograph drugs | November 1, 2019 |
| Even and Clear Cleanser | 73453-003 | Liquid | Over the counter monograph drugs | June 15, 2014 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.